Neonatal CD4+ T cells have traditionally been viewed as deficient in their capacity to produce Th-1 cytokines in response to polyclonal or antigen specific stimuli. Thus, defining unique aspects of CD4+ T cell activation and development into Th-1 effector cells in neonates is essential to the successful development of novel vaccines and immunotherapies to protect infants from intracellular pathogens. Using highly purified naïve CD4+ T cells derived from cord and adult peripheral blood, we compared the impact of anti-CD3 stimulation plus co-stimulation through TLR-2 performed in the absence of APC, on CD4+ T cell cytokine production, proliferation, and expression of activation markers. In both age groups, TLR-2 co-stimulation elicited activation of naïve CD4+ T cells, characterized by robust production of IL-2 as well as key Th-1 type cytokines IFN-γ and TNF-α. TLR-2 co-stimulation also dramatically reduced naïve T cell production of the immunosuppressive cytokine IL-10. We observed that neonatal naïve CD4+ T cells are uniquely sensitive to TLR-2 mediated co-stimulation, which enabled them to produce equivalent amounts of IFN-γ and more IL-2 when compared to adult responses. Thus, neonatal CD4+ T cells have a distinctive propensity to utilize TLR-2 mediated co-stimulation for development into pro-inflammatory Th-1 effectors, and interventions that target CD4+ T cell TLR-2 mediated responses may be exploited to enhance neonatal adaptive immunity.